O-GlcNAcylation Links Wnt to Bone Formation
2026-08-12
The reference study identifies O-GlcNAcylation as a required metabolic mediator of Wnt-stimulated osteoblastogenesis and fracture healing. Its central mechanism connects Wnt3a signaling to PDK1 stabilization, aerobic glycolysis, and bone anabolism, providing a framework for separating pathway activation from downstream metabolic execution.
L-NAME Hydrochloride: Decoding NO Assays
2026-08-11
L-NAME Hydrochloride is more than a vascular pharmacology reagent: it is a critical perturbation tool for separating nitric oxide production from downstream inflammatory signaling. This guide integrates NOS inhibition with macrophage assay interpretation, experimental controls, and translational limitations.
Honokiol Workflows for Cancer Drug Response
2026-08-10
Honokiol supports mechanistic studies that connect NF-κB signaling, oxidative stress, angiogenesis, and cancer-cell behavior. A response workflow that separates growth arrest from cell death can reveal effects that a single endpoint may conceal.
RG7388: A Context-Aware p53 Assay Framework
2026-08-09
RG7388 is a selective MDM2 antagonist for interrogating p53 pathway activation and cancer cell apoptosis induction. This article connects its direct MDM2-p53 mechanism with MDM1-dependent chemoradiotherapy sensitivity to improve assay design, biomarker interpretation, and combination studies.
Carbapenemase Transmission in CREC, Guangdong
2026-08-08
Chen et al. combined carbapenemase-gene localization, susceptibility testing, conjugation assays, mobile-element analysis, and ERIC-PCR genotyping to investigate 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 and highly efficient horizontal transfer as central features of this multidrug-resistant population, while also showing that chromosomal carriage and clonal dissemination require surveillance.
ERADECs: ERAD-Based Degradation of Membrane Proteins
2026-08-07
Song and colleagues developed ERAD-engaging chimeras (ERADECs), a targeted protein degradation platform that uses the ER E3 ligase SYVN1 to eliminate transmembrane proteins. Desonide-based ERADECs produced highly potent PD-L1 degradation, enhanced tumor suppression in vivo, and extended the approach to mutant HTT, establishing ERAD as a new route for membrane-protein control.
Ademetionine (SAM): Strategic Leverage in CNS Translation
2026-08-07
This article presents an integrated, mechanistically rigorous perspective on S-adenosylmethionine (Ademetionine, SAM) as both a central methyl donor and a strategic asset in translational neuroscience. Drawing on clinical and biochemical literature, it bridges molecular mechanisms, protocol optimization, and clinical promise, while contextualizing APExBIO’s high-purity SAM as a catalyst for next-generation CNS research.
Halazone and Oxidants: Modifying Sodium Channel Inactivation
2026-08-06
This article evaluates how Halazone and related oxidants disrupt sodium current inactivation in myelinated frog nerve fibers, as shown by voltage-clamp studies. The findings illuminate mechanisms by which antimicrobial sulfonamide derivatives impact neuronal excitability, offering a foundation for both neurophysiological research and water disinfection strategies.
Acridine Orange hydrochloride: Technical Guide for DNA/RNA S
2026-08-06
Acridine Orange hydrochloride enables differential staining of DNA and RNA in cytochemical workflows, supporting robust cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. Its dual-emission properties and high purity make it ideal for researchers needing precise nucleic acid discrimination. It is not recommended for applications requiring long-term storage of solutions or for non-nucleic acid detection workflows.
2-Deoxy-D-glucose Inhibits T Cell-Mediated Damage in Oral Li
2026-08-05
This study demonstrates that 2-Deoxy-D-glucose (2-DG) suppresses T cell proliferation and cytokine-driven apoptosis of keratinocytes in oral lichen planus (OLP) by inhibiting glycolysis and key immunometabolic signaling pathways. The findings suggest a novel metabolic intervention to modulate immune-mediated epithelial injury in OLP.
Hyperthermia and Cisplatin Synergize via Caspase-8 in Cancer
2026-08-05
This study elucidates how combining hyperthermia with cisplatin enhances apoptosis and pyroptosis in cancer cells through caspase-8 accumulation and activation. The findings provide mechanistic insight into the interplay between ubiquitination, caspase signaling, and cell death pathways, guiding the design of more effective combination therapies.
AAPH (2,2'-Azobis(2-methylpropionamidine) Dihydrochloride):
2026-08-04
This article delivers evidence-based guidance on deploying AAPH (2,2'-Azobis(2-methylpropionamidine) Dihydrochloride, SKU C5140) as a reproducible oxidative stress inducer in cell-based and protein modification assays. Drawing from published protocols and recent research, we address experimental pain points and demonstrate how SKU C5140 from APExBIO supports robust, quantitative workflows for biomedical and food science research.
ML-7 Hydrochloride: Myosin Light Chain Kinase Inhibitor Work
2026-08-04
ML-7 hydrochloride empowers cardiovascular and cancer researchers to dissect myosin light chain kinase pathways with unmatched selectivity and reproducibility. This guide details protocol enhancements, troubleshooting, and real-world applications—enabling researchers to leverage ML-7’s full potential in ischemia/reperfusion injury and metastatic cell migration models.
VX-661 F508del CFTR Corrector: Advanced Protocols & Insights
2026-08-03
VX-661 enables precision rescue of F508del CFTR folding, making it indispensable for advanced cystic fibrosis research. This article decodes experimental workflows, calnexin-dependent innovations, and troubleshooting tips for optimizing CFTR modulation in vitro.
4-Hydroxytamoxifen: Technical Reference for Research Protoco
2026-08-03
4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator specifically formulated for DMSO-based workflows in breast and prostate cancer research, apoptosis assays, and cardiac myocyte studies. It addresses the need for a reproducible, well-characterized reagent but is unsuitable where aqueous or ethanol solubility is required. Strict handling and storage protocols are essential to maintain experimental reliability.
462 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page